ArticleJSES international2025
Projections of utilization of primary and revision shoulder arthroplasty in the United States in the next 40 years.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Custom humeral antibiotic spacers for complex shoulder arthroplasty revision: technical principles and case illustrations.JSES reviews, reports, and techniques · 2026Article
- Custom distal humerus reconstruction for severe bone loss in revision and complex primary total elbow arthroplasty.JSES reviews, reports, and techniques · 2026Article
- Modifiable pre-operative physiological predictors of length of stay following shoulder arthroplasty: a systematic review.JSES reviews, reports, and techniques · 2026Review
- Impact of pre-operative dementia or cognitive impairment on outcomes after elective primary total shoulder arthroplasty.Journal of shoulder and elbow arthroplasty · 2026Article
- Intravenous versus oral tranexamic acid in shoulder arthroplasty.Archives of orthopaedic and trauma surgery · 2026Article
- Shoulder Procedure Volumes in Orthopaedic Residency: Long-Term Disparities and a Case for Arthroplasty Minimums.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026Article
- Pre-operative methicillin-resistantJournal of shoulder and elbow arthroplasty · 2026Article
- Pre-operative antiplatelet therapy is associated with increased risk of periprosthetic joint infection following total shoulder arthroplasty.Journal of shoulder and elbow arthroplasty · 2026Article
- Prior cervical spine fusion impairs early clinical outcomes following total shoulder arthroplasty and may be associated with increased fusion burden: a matched cohort analysis.JSES international · 2026Article
- Tranexamic acid utilization remains low in anatomical and reverse total shoulder arthroplasty despite decreased postoperative complications: A propensity-matched analysis.Shoulder & elbow · 2026Article
- Effect of prior mastectomy on outcomes following total shoulder arthroplasty.Archives of orthopaedic and trauma surgery · 2026Article
- Metformin does not decrease the incidence of shoulder arthroplasty in patients with glenohumeral joint osteoarthritis.JSES reviews, reports, and techniques · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the past 20 years, the incidence of total shoulder arthroplasty (TSA) has increased greatly, and it is expected to continue growing. Current literature lacks future projections for the utilization of TSA. These projections can help predict demand quantities and anticipate the future burden on the healthcare system. The aim of this study is to determine the predictions of utilization for TSA, primary and revision, through 2060. Methods: This analysis used the publicly available 2000-2019 data from the Center for Medicare and Medicaid Services Medicare Part-B National Summary. Procedure volumes, including TSA and revision TSA, were determined using Current Procedural Terminology codes and were uplifted to account for the growing number of Medicare eligible patients covered under Medicare Advantage. Log-linear, Poisson, negative binomial regression, and autoregressive integrated moving average models were applied to the procedural volumes to generate projections from 2020-2060. The Poisson model was chosen to display the data based on error analysis and prior literature. Results: The projected annual growth from 2020 to 2060 rates for primary and revision TSA are 11.65% growth (95% confidence interval 11.60%-11.69%) and 13.89% growth (95% confidence interval 13.35%-14.42%), respectively. By 2060, the demand for primary TSA and revision TSA is projected to be 10,029,260 and 1,690,634, respectively. Conclusion: The results of this study concluded that both primary and revision TSA procedures are projected to exponentially increase from 2020 to 2060. Additionally, revision procedures are projected to increase at greater rates than their respective primary counterparts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.